Gluten-detection devices and telemedicine to help adults with celiac disease
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
This project looks at whether using portable gluten sensors and urine gluten tests together with telemedicine can help adults with celiac disease stick to a gluten-free diet and feel better.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11370961 on NIH RePORTER |
What this research studies
If you have celiac disease, this project would pair regular telehealth visits with dietitians and home gluten-detection tools you can use on food or in urine. Participants will be taught to use portable gluten sensors and urine gluten immunogenic peptide kits and will report results to their care team during virtual visits. The research team will track diet adherence, symptoms, blood tests, and quality of life over time to see if the tools help reduce accidental gluten exposure. Some visits or tests may require occasional in-person follow-up at the study center.
Who could benefit from this research
Good fit: Adults diagnosed with celiac disease who are willing to use home gluten-detection tools and participate in telehealth visits are ideal candidates.
Not a fit: People without celiac disease, children, or adults who are already strictly adherent to a gluten-free diet with no ongoing symptoms may not receive direct benefit.
Why it matters
Potential benefit: If successful, this approach could help people with celiac disease reduce accidental gluten exposure, improve symptoms, and make diet management easier.
How similar studies have performed: Smaller studies have shown gluten sensors and urine gluten peptide tests can detect exposures and telemedicine can support dietary care, but large controlled trials showing clear patient benefit are still limited.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Lebwohl, Benjamin — Columbia University Health Sciences
- Study coordinator: Lebwohl, Benjamin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.